Yuzhou Gui

582 total citations · 1 hit paper
17 papers, 409 citations indexed

About

Yuzhou Gui is a scholar working on Molecular Biology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, Yuzhou Gui has authored 17 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Analytical Chemistry. Recurrent topics in Yuzhou Gui's work include Analytical Methods in Pharmaceuticals (4 papers), Cholesterol and Lipid Metabolism (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Yuzhou Gui is often cited by papers focused on Analytical Methods in Pharmaceuticals (4 papers), Cholesterol and Lipid Metabolism (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Yuzhou Gui collaborates with scholars based in China and United Kingdom. Yuzhou Gui's co-authors include Hongchao Zheng, Richard Y. Cao, Fei Gao, Hong Yan, Gangyi Liu, Yiping Wang, Jingying Jia, Chen Yu, Cong Xi and Yiping Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cardiovascular Research.

In The Last Decade

Yuzhou Gui

17 papers receiving 401 citations

Hit Papers

Foam Cells in Atherosclerosis: Novel Insights Into Its Or... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms
    2022 154 citations Yuzhou Gui, Hongchao Zheng et al. Frontiers in Cardiovascular Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuzhou Gui China 9 174 83 71 60 51 17 409
Wei‐Bang Yu China 11 161 0.9× 98 1.2× 29 0.4× 28 0.5× 44 0.9× 15 402
Waseem El‐Huneidi United Arab Emirates 15 257 1.5× 59 0.7× 73 1.0× 54 0.9× 93 1.8× 61 653
Pengzhi Dong China 10 138 0.8× 59 0.7× 76 1.1× 42 0.7× 43 0.8× 15 321
Luxiao Li China 9 296 1.7× 84 1.0× 93 1.3× 30 0.5× 125 2.5× 10 681
Yanfang Yang China 16 264 1.5× 58 0.7× 41 0.6× 59 1.0× 84 1.6× 35 605
Youli Lu China 11 136 0.8× 48 0.6× 38 0.5× 32 0.5× 21 0.4× 23 335
Zhu-Jun Mao China 15 251 1.4× 32 0.4× 63 0.9× 46 0.8× 84 1.6× 39 554
Akihiro Sekiguchi Japan 10 225 1.3× 30 0.4× 83 1.2× 30 0.5× 29 0.6× 15 528
Haiyan Sun China 8 242 1.4× 65 0.8× 42 0.6× 54 0.9× 62 1.2× 22 519

Countries citing papers authored by Yuzhou Gui

Since Specialization
Citations

This map shows the geographic impact of Yuzhou Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzhou Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzhou Gui more than expected).

Fields of papers citing papers by Yuzhou Gui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzhou Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzhou Gui. The network helps show where Yuzhou Gui may publish in the future.

Co-authorship network of co-authors of Yuzhou Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Yuzhou Gui. A scholar is included among the top collaborators of Yuzhou Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzhou Gui. Yuzhou Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
Cheng, Jie, Yuzhou Gui, Wei Wang, et al.. (2023). A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects. Clinical and Translational Science. 16(9). 1704–1712. 2 indexed citations
4.
Gui, Yuzhou, Hongchao Zheng, & Richard Y. Cao. (2022). Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms. Frontiers in Cardiovascular Medicine. 9. 845942–845942. 154 indexed citations breakdown →
5.
Gui, Yuzhou, Liqing Li, Ze Chen, et al.. (2022). Development and validation of a ligand-binding assay for quantification of the F(ab')2 antivenom of Daboia russelii siamensis in human serum and its application to a phase I clinical study. Journal of Pharmaceutical and Biomedical Analysis. 212. 114645–114645. 1 indexed citations
6.
Zhang, Mengqi, Yuzhou Gui, Jingying Jia, et al.. (2020). Liquid chromatography-tandem mass spectrometric assay for TPN171 in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 191. 113634–113634. 1 indexed citations
7.
8.
Liu, Gangyi, Xiaohui Liu, Yuzhou Gui, et al.. (2018). Proteomics analysis reveals a potential new target protein for the lipid-lowering effect of Berberine8998. Acta Pharmacologica Sinica. 39(9). 1473–1482. 4 indexed citations
9.
Gui, Yuzhou, Hong Yan, Fei Gao, et al.. (2016). Betulin attenuates atherosclerosis in apoE−/− mice by up-regulating ABCA1 and ABCG1. Acta Pharmacologica Sinica. 37(10). 1337–1348. 32 indexed citations
10.
Gui, Yuzhou, Sheng Yao, Hong Yan, et al.. (2016). A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Cardiovascular Research. 112(1). 502–514. 29 indexed citations
11.
Liu, Gangyi, Chunxia Dong, Weiwei Shen, et al.. (2015). Development and validation of an HPLC–MS/MS method to determine clopidogrel in human plasma. Acta Pharmaceutica Sinica B. 6(1). 55–63. 11 indexed citations
12.
Jia, Jingying, Gangyi Liu, Mengqi Zhang, et al.. (2015). Determination of the novel antiarrhythmic drug sulcardine sulfate in human plasma by liquid chromatography tandem mass spectrometry and its application in a clinical pharmacokinetic study. Biomedical Chromatography. 30(8). 1291–1296. 2 indexed citations
13.
14.
Yan, Hong, Yanling Ma, Yuzhou Gui, et al.. (2014). MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression. Acta Pharmacologica Sinica. 35(8). 994–1004. 31 indexed citations
15.
Jia, Jingying, Qianhua Zhao, Yun Liu, et al.. (2013). Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease. Acta Pharmacologica Sinica. 34(7). 976–982. 42 indexed citations
16.
Lü, Chuan, Gangyi Liu, Jingying Jia, et al.. (2010). Liquid chromatography tandem mass spectrometry method for determination of N‐acetylcysteine in human plasma using an isotope‐labeled internal standard. Biomedical Chromatography. 25(4). 427–431. 19 indexed citations
17.
Lü, Chuan, Jingying Jia, Yuzhou Gui, et al.. (2009). Development of a liquid chromatography–isotope dilution mass spectrometry method for quantification of fentanyl in human plasma. Biomedical Chromatography. 24(7). 711–716. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐Bang Yu Breakdown of academic impact, for papers by Waseem El‐Huneidi Breakdown of academic impact, for papers by Pengzhi Dong Breakdown of academic impact, for papers by Luxiao Li Breakdown of academic impact, for papers by Yanfang Yang Breakdown of academic impact, for papers by Youli Lu Breakdown of academic impact, for papers by Zhu-Jun Mao Breakdown of academic impact, for papers by Akihiro Sekiguchi Breakdown of academic impact, for papers by Haiyan Sun
Rankless by CCL
2026